0001213900-20-029374.txt : 20200930
0001213900-20-029374.hdr.sgml : 20200930
20200930210149
ACCESSION NUMBER: 0001213900-20-029374
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200929
FILED AS OF DATE: 20200930
DATE AS OF CHANGE: 20200930
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Patel Snehal
CENTRAL INDEX KEY: 0001806920
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39555
FILM NUMBER: 201214024
MAIL ADDRESS:
STREET 1: 2311 SPARTAN TRAIL
CITY: SUGAR LAND
STATE: TX
ZIP: 77479
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Greenwich LifeSciences, Inc.
CENTRAL INDEX KEY: 0001799788
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205473709
STATE OF INCORPORATION: TX
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3992 BLUEBONNET DR, BUILDING 14
CITY: STAFFORD
STATE: TX
ZIP: 77477
BUSINESS PHONE: 203-434-3290
MAIL ADDRESS:
STREET 1: 3992 BLUEBONNET DR, BUILDING 14
CITY: STAFFORD
STATE: TX
ZIP: 77477
4
1
ownership.xml
X0306
4
2020-09-29
0
0001799788
Greenwich LifeSciences, Inc.
GLSI
0001806920
Patel Snehal
C/O GREENWICH LIFESCIENCES, INC.
3992 BLUEBONNET DR., BUILDING 14
STAFFORD
TX
77477
1
1
0
0
CEO and CFO
Common Stock
2020-09-29
4
M
0
176448
A
1040131
D
Common Stock
2020-09-29
4
M
0
13736
A
1053867
D
Common Stock
2020-09-29
4
M
0
10394
A
1064261
D
Common Stock
2020-09-29
4
M
0
103911
A
1168172
D
Common Stock
2020-09-29
4
M
0
1144529
A
1321327
I
see footnote
Common Stock
2020-09-29
4
M
0
2997
A
1324324
I
see footnote
Common Stock
2020-09-29
4
M
0
33708
A
1358032
I
see footnote
Common Stock
2020-09-29
4
M
0
50001
A
1408033
I
see footnote
Common Stock
2020-09-29
4
M
0
76780
A
76780
I
see footnote
Common Stock
2020-09-29
4
M
0
52620
A
129400
I
see footnote
Common Stock
2405670
I
see footnote
Common Stock
1320226
I
see footnote
Common Stock
1329590
I
see footnote
Series A Preferred Stock
2020-09-29
4
M
0
176448
0
D
Common Stock
176448
0
D
Series A Preferred Stock
2020-09-29
4
M
0
1144529
0
D
Common Stock
1144529
0
I
see footnote
Series B Preferred Stock
2020-09-29
4
M
0
13736
0
D
Common Stock
13736
0
D
Series B Preferred Stock
2020-09-29
4
M
0
76780
0
D
Common Stock
76780
0
I
see footnote
Series B Preferred Stock
2020-09-29
4
M
0
2997
0
D
Common Stock
2997
0
I
see footnote
Series C Preferred Stock
2020-09-29
4
M
0
10394
0
D
Common Stock
10394
0
D
Series C Preferred Stock
2020-09-29
4
M
0
33708
0
D
Common Stock
33708
0
I
see footnote
Series D Preferred Stock
2020-09-29
4
M
0
89510
0
D
Common Stock
89510
0
D
Series D Preferred Stock
2020-09-29
4
M
0
45328
0
D
Common Stock
45328
0
I
see footnote
Series D Preferred Stock
2020-09-29
4
M
0
43072
0
D
Common Stock
43072
0
I
see footnote
Series D Preferred Stock
2020-09-29
4
J
0
14401
0
A
Common Stock
14401
14401
D
Series D Preferred Stock
2020-09-29
4
J
0
6929
0
A
Common Stock
6929
6929
I
see footnote
Series D Preferred Stock
2020-09-29
4
J
0
7292
0
A
Common Stock
7292
7292
I
see footnote
Series D Preferred Stock
2020-09-29
4
M
0
14401
0
D
Common Stock
14401
0
D
Series D Preferred Stock
2020-09-29
4
M
0
6929
0
D
Common Stock
6929
0
I
see footnote
Series D Preferred Stock
2020-09-29
4
M
0
7292
0
D
Common Stock
7292
0
I
see footnote
The securities are owned by Snehal Patel IRA. Snehal Patel is the Trustee of Snehal Patel IRA, and in such capacity is deemed to hold voting and dispositive power over the securities held by such IRA.
Kinnary Patel is the spouse of Snehal Patel and Trustee of the Kinnary Patel IRA.
The securities are owned by Patel Family Trust 1. Snehal Patel, as co-Trustee of Patel Family Trust 1, shares voting and dispositive power over the securities held by such trust with his spouse.
The securities are owned by Patel Family Trust 2. Snehal Patel, as co-Trustee of Patel Family Trust 2, shares voting and dispositive power over the securities held by such trust with his spouse.
The securities are owned by Patel Family Trust 3. Snehal Patel, as co-Trustee of Patel Family Trust 3, shares voting and dispositive power over the securities held by such trust with his spouse.
The Series A Preferred Stock converted into Issuer common stock on a 1-for-1 basis and had no expiration date.
The Series B Preferred Stock converted into Issuer common stock on a 1-for-1 basis and had no expiration date.
The Series C Preferred Stock converted into Issuer common stock on a 1-for-1 basis and had no expiration date.
The Series D Preferred Stock converted into Issuer common stock on a 1-for-1 basis and had no expiration date.
The Series D Preferred Stock have no expiration date and are convertible, at the option of the holder, into shares of common stock of the Issuer at the then-effective conversion rate for no additional consideration (subject to the payment of cash, if applicable, in lieu of any fractional shares in accordance with the Issuer's Amended and Restated Certificate of Incorporation, as amended (the "Certificate of Incorporation").
The Reporting Person was issued additional shares of Series D Preferred Stock in connection with the Issuer's initial public offering as a result of the anti-dilution protection provisions set forth in the Issuer's Certificate of Incorporation.
/s/ Snehal Patel
2020-09-30